ReviewMolecular diagnosis & therapy2013

Erlotinib : a guide to its use in first-line treatment of non-small-cell lung cancer with epidermal growth factor-activating mutations.

Katherine A Lyseng-WilliamsonPubMed ↗Publisher ↗

No numbers read from the abstract.